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Purpose: Vascular surgeons are ideally suited to select and perform endovascular interven- 
tions either as primary therapy or as an adjunct o bypass surgery. Attaining proficiency in 
endovascular techniques is an important goal in the training of vascular surgeons. We 
report our initial experience with a program of endovascular intervention performed in 
the operating room by vascular surgeons. 
Methods: During the previous three years, we performed 109 angioplasty procedures, 60 
aortoiliac (55%), 32 femoropopliteal (29%), and 17 popliteal/tibial (16%), using guide- 
wires and angioplasty balloons directed by intraoperative digital subtraction C-arm 
arteriography with road-mapping capabilities. Indications for angioplasty included dis- 
abling clandication i  59 patients (54%), rest pain in 18 (17%), and tissue loss in 32 (29%). 
Angioplasty was accompanied by stent placement in 39 of 60 aortoiliac procedures (65%) 
and in two of 32 femoral procedures (6%). In 16 cases (15%), the endovascular p ocedure 
was performed in conjunction with a bypass procedure. In selected cases (15, 14% ), duplex 
scanning was the sole diagnostic method used before surgery to identify the lesion, 
eliminating the need for preoperative arteriographic s ans. Segmental pressure measure- 
ments, duplex ultrasound scans, and treadmill exercise testing as indicated were per- 
formed before and after surgery. The efficacy of the endovascular intervention was 
assessed at 3-month intervals during the first year and at &month intervals thereafter. 
Results: A successfifl result was defined using criteria recommended bythe Ad Hoc Subcom- 
mittee on Reporting Standards for Endovascular Procedures from the Society for Vascular 
Surgery/International Society for Cardiovascular Surgery. This included the combination of 
symptomatic hnprovement, obtaining an anatolnically successful result with <30% residual 
lumen stenosis, and elimination of the translesion gradient with an improvement in high 
thigh-brachial index or ankle-brachial index greater than 0.15. Initial success was achieved in 
55 of 60 aortoiliac (92%), 28 of 32 femoropopliteal (88%), and 16 of 17 popliteal/tibial 
(94%) angioplasty procedures. Clinical follow-up has been achieved in all cases, with contin- 
ued clinical success rates of 80%, 75%, and 82% for aortoiliac, femoropopliteal~ nd popliteal/ 
tibia/angioplasty procedures, respectively, with a mean follow-up of 15.7 months. 
Conclusion: These results confirm the value of a program in which C-arm technology was 
used by vascular surgeons in the performance of angioplasty and stenting procedures in 
the operating room. This experience in therapeutic endovascular intervention will facili- 
tate the credentialing process for future vascular surgeons. (J Vase Surg 1996;24:963-73.) 
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Vascular surgeons traditionally have managed pa- 
tients who have a wide range of  vascular disease and 
they thereby offer superior diagnostic and therapeutic 
options. This encompasses the selection and perfor- 
mance ofendovascular p ocedures. Our approach as 
been to establish an intervenfionai program in the 
operating room, whereas othcrs have addressed the 
issue by establishing a referral relationship with an 
interventional radiologist or cardiologist. This collab- 
orative approach, however, has some theoretic lirni- 
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tations. Responsibility to the patient for complica- 
tions that result from procedures that are performed 
by others and the issue ofpreprocedural surgical evalu- 
ation and clinical diagnostic follow-up on a procedure 
performed by a colleague resulted in our decision to 
pursue a program of operative ndovascular interven- 
tion for iliac and femoropopliteal occlusive disease. 
The task of determining how a vascular surgeon 
can deliver these services, however, has frustrated the 
advancement of this portion of our practice and com- 
plicated our attempts to add an endovascular compo- 
nent to our training program. Four alternative loca- 
tions and collaborative approaches exist: using the 
angiography suite, using the cardiology suite, estab- 
lishing an independent facility, or using an existing 
facility such as the operating room. The first and 
second alternative approaches involve the interdisci- 
plinary use of space, which in many instances is not 
feasible. The development of the freestanding unit 
may be the ideal approach, but it probably would be 
a complex and expensive undertaking in most insti- 
tutions. The operating suite then represents the pre- 
ferred option for the development of an endovascular 
program that is managed by vascular surgeons. 
Our objective was to demonstrate the utility of 
using conventional C-arm imaging techniques, 
which are available in virtually all operating suites, to 
establish a surgically based program in endovascular 
therapeutics. Our goal was to use these techniques as 
alternatives to standard vascular surgical procedures 
or as adjuncts to more complex arterial revasculariza- 
tion procedures. 
The first author of the report on this series under- 
went a formal 1-year fellowship n diagnostic and 
therapeutic angiographic endovascular intervention 
in addition to a standard 2-year vascular surgical 
fellowship. The second and third authors had had 
substantial experience in the development and the 
evaluation of laser-assisted angioplasty procedures. 
They have desseminated this experience within the 
division to our vascular surgical trainees and to our 
vascular attending surgeons by a policy of planned 
proctoring. All of  the surgeons who perform these 
procedures have done so only after having met the 
credentialing criteria that are outlined by the Ad Hoc 
Committee on Credentialing of the Joint Councils of 
the vascular surgical societies) 
PAT IENTS AND METHODS 
Patients were candidates for endovascular inter- 
vention if they reported lifestyle-limiting claudication 
refractory to standard exercise regimens and smoking 
cessation, or alternatively demonstrated rest pain or 
ischemic tissue loss. Either angiographic or duplex ul- 
trasound scans were performed before surgery to iden- 
tify lesions that were potentially amenable to treatment. 
Patient assessment 
Clinical evaluation. Stratification of patients on 
the basis of their symptoms was performed using rec- 
ommendations outlined by the Ad Hoc Subcommittee 
on Reporting Standards for Endovascular Procedures. 2 
The clinical grades I (clandication), II (rest pain), and 
III (tissue loss) were determined for all patients. 
Hemodynamic assessment. Doppler-derived seg- 
mental pressure measurements and computed ankle- 
brachialindexes (ABI) and thigh-brachial indexes (TBI) 
were obtained in all cases. Postexercise index measure- 
ments, pulse-volume recordings, and Doppler scans 
were performed in selected cases. 
Risk factors. Patients were classified according 
to their history of smoking, hypertension, diabetes 
mellitus, hypercholesterolemia, renal insufficiency 
with a creatinine level greater than 2.0 mg/dl ,  
chronic obstructive pulmonary disease, or coronary 
artery disease. 
Description of  lesion 
Location. We classified all lesions by anatomic 
site, using three groups: aortoiliac (including aorta 
and common iliac and external iliac arteries), femo- 
ropopliteal (including common femoral, deep femo- 
ral, superficial femoral, and above-lmee popliteal ar- 
teries), and popliteal/tibial (including below-lmee 
popliteal, anterior fibial, tibioperoneal trunk, poste- 
rior tibial, and peroneal rteries). 
Type. Using information obtained from a review 
of preoperative or intraoperafive angiographic scans 
or duplex scans, we characterized lesions according to 
occlusion versus stenosis, combined with measure- 
ments of length and assessment ofrunoffvessels. The 
length of the treated lesion was separated into the 
following categories: <2 cm, >2 cm to 5 cm, >5 cm 
to 10 cm, and >10 cm. The status of the runoff 
arteries was graded as either poor (0 to 1) or good (2 
to 3). Runoff was defined as an adequately patent 
artery distal to the treated site (<50% stenosis by 
angiographic appearance or its equivalent on Duplex 
scan). The superficial and deep femoral arteries are 
the runoff vessels for iliac artery lesions, and the tibial 
arteries are the runoff vessels for procedures per- 
formed on femoral or popliteal arteries. 
Criteria for early success 
The treatment outcome was based on an intent- 
to-treat protocol and included all patients who con- 
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sented to undergo the procedure in the operating 
room. When more than one procedure was per- 
formed on the same arterial segment (i.e., common 
iliac angioplasty followed by deployment of a stent, 
and repeat post-stent deployment angioplasty), this 
was reported as a single endovascular p ocedure, with 
efficacy being determined by final outcome of  all 
component procedures. 
When the endovascular p ocedure was performed 
in conjunction with a surgical reconstruction rwith 
another endovascular p ocedure of an adjacent inflow 
or outflow vascular bed, the patency rates of  each 
vascular bed were reported separately. Clinical or 
hemodynamic failures for either component of  ther- 
apy in these patients, however, were reported as being 
failures for both procedures. 
The therapeutic results were based on the clinical, 
hemodynamic, and imaging or anatomic factors. All 
three criteria must have shown improvement in order 
for the result to be counted as a success. The defini- 
tions for success for each factor are outlined below. 
Clinical success. Clinical success required symp- 
tomatic improvement of the patient as compared 
with their preprocedural ssessment. Claudication 
was improved if resolved or improved greater than 
50%. Rest pain must have been resolved, and tissue 
loss required healing with limb salvage. 
Hemodynamic  improvement.  Hemodynamic 
improvement was defined as an improvement in the 
high thigh-brachial index greater than 0.15 for pa- 
tients undergoing aortoiliac procedures, or improve- 
ment in the anlde-brachial index greater than 0.15 for 
patients undergoing femoropopliteal or popliteal/ 
tibial procedures. 
Anatomic success. Initial anatomic success was 
defined as a residual luminal stenosis < 30% of normal 
diameter as measured by an intraoperative digital- 
subtraction angiographic scan. It should be noted 
that the successful passage of a wire or device across a 
lesion alone without angiographic evidence of ade- 
quate restoration of lumen size and elimination of the 
translesion pressure gradient was not considered an 
initial technical success, but rather was recorded as 
being a failed procedure. 
Criteria for cont inued success 
The, above criteria for immediate success applied 
to immediate postprocedural results. Continued suc- 
cess was determined once the patient was discharged 
and is defined as maintenance of the same criteria 
listed above for clinical, hemodynamic, and anatomic 
success. Clinical patency was based on sustained im- 
provement of at least one objective hemodynamic or
imaging test in addition to sustained clinical improve- 
ment. A deterioration of one or more category level 
clinically or hemodynamically constituted failure. An- 
atomic failure is defined as restenosis to >-50% of 
normal diameter as seen on angiographic assessment 
or doubling of velocities as evidenced by duplex scan. 
Patients were evaluated at 3-month intervals for the 
first year and 6-month intervals thereafter. 
Perioperative factors 
Endovascular procedures were performed either 
by percutaneous approach or by arterial cutdown. 
Typically, a 0.03S-inch ydrophilic Glidewire (Med- 
itech, Boston Scientific. Watertown, Mass.) was ad- 
vanced across the lesion and a 5F introducer sheath 
was placed. One of a variety of  angiocatheters (Med- 
itech) would be selected on the basis of anatomic 
considerations and advanced over the wire for injec- 
tion of  contrast material and subsequent pressure 
measurements. Operative Lmaging was accomplished 
using C-arm digital subtraction arteriography ~OEC 
Medical Systems, Inc., Salt Lake City). Standard an~ 
teroposterior views were routinely augmented with 
oblique views, and minimal-volume (510 mB hand 
injections of contrast material were used to confirm 
location and severity of occlusive lesions. The pres- 
sure measurements above and below the lesion were 
obtained before intervention. Papaverine injections 
were used when necessary to evaluate gradients; a
10% reduction in pressure across the lesion was con- 
sidered significant Ultrathin angloplasty balloons 
(Meditcch) were selected on the basis of arterial 
measurements; commonly for an iliac angioplasty a 4 
cm × 8 mm balloon would be positioned and inflated 
to 12 atmospheres of  pressure using an inflation 
device and the pressure would be sustained for a 
period of  30 seconds. Patients received a SO00-unit 
bolus ofheparin sulfate intravenously before inflation 
of the angioplasty balloons. 
Premounted Palmaz stents (Johnson & Johnson, 
Princeton, N.J. ~ were selected for deployment when 
angioplasty failed to relieve the translesion pressure 
gradient or when a technically unsatisfactory esult 
with angioplasty (dissection or residual intraluminal 
stenosis >30%) was noted. Stent sxzes were selected 
on the basis of  arterial measurements and introduced 
through the SF sheath when possible. I f  a 7F intro- 
ducer was required (necessary for stents larger than 9 
mm in diameter), sequential dilators were used to 
facilitate the exchange. Stent deployment after dila- 
tion angioplasty with the next-higher-size balloon 
catheter was then performed for maximal stent to 
arterial wall apposition. Completion arteriographic 
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Table I. Patient comorbidities and 
risk factors 
Characteristic Percent 
Hypertension 56 
Diabetes mellitus 47 
Coronary artery disease 44 
Smoking 59 
Chronic pulmonary disease 16 
Hypercholester01emia 9 
Stroke 8 
Creatinine >2.0 2 
scans and pressure measurements were obtained in all 
patients before removal of the introducer sheath. 
Once removed, if the procedure had been performed 
from a percutaneous approach, pressure was held for 
a minimum period of 20 minutes or as necessary to 
achieve hemostasis. 
All patients were discharged on antiplatelct ther- 
apy (acetylsalicylic a id, 325 mg daily). Preprocedure 
and postprocedure thigh-brachial indexes and ankle- 
brachial indexes were expressed as mean + SD. Ap- 
parent differences were assessed for their statistical 
significance by performing X 2 analysis. 
RESULTS 
Between October 1993 and March 1996, we 
performed 109 angioplasty procedures and 41 in- 
traarterial stent deployment procedures in68 patients 
who had been referred for evaluation of peripheral 
vascular disease. The male-to-female distribution was 
56% male and 44% female, and the mean age of 
patients treated was 66.7 years, with a range of 43 to 
88 years. Table I summarizes the frequencies of co- 
morbid illnesses and selected risk factors. 
Indications for endovascular intervention were 
disabling claudication i 49%, rest pain in 18%, and 
tissue loss in 33% of the procedures performed. Table 
II describes the distribution of lesions and their char- 
acteristics. 
Of the 60 aortoiliac angioplasty procedures per- 
formed (one aortic, 32 common iliac, and 27 external 
iliac), stents were used in 39 (65%). Of the 32 femo- 
ropopliteal rtery angioplasty procedures performed, 
stents were used in two (6%). In no instance was a 
stent deployed below the level of the popliteal artery 
to accompany tibial angioplasty. Of the 41 stents 
deployed, 16 (39%) were used when there was a 
persistent translesion pressure gradient, and 25 (61%) 
were used for a poor anatomic result after angioplasty 
with either esidual stenosis >30% (21 procedures) or
with angiographic evidence of arterial wall dissection 
(four procedures). One of the femoral stents was 
Table II; Description of lesion 
Characteristic No. of lesions Percent of total 
Location 
Aortoiliac 60 55 
Femoropopliteal 32 29 
Popliteal/tibial 17 16 
Type 
Occlusion 6 6 
Stenosis 103 94 
Length 
-<2 cm 10 9 
2 cm to 5 cm 60 55 
5 cm to 10 cm 20 18 
>10 cm 19 17 
Runoff 
Good (0 to 1 vessel) 47 43 
Poor (2 to 3 vessels) 62 57 
placed in a patient who had documented blue toe 
syndrome and a heavily calcified superficial femoral 
artery lesion refractory to angioplasty; 13 months 
after the procedure was performed, this patient had 
resolution of her symptoms and normal distal circu- 
lation. 
Of the 60 procedures that were performed in the 
aortoiliac location, five performed in four patients 
were considered immediate failures. One patient who 
had a known hypercoagulable condition and severe 
cardiac and pulmonary comorbidity was being 
treated for lower extremity ischemia manifested by 
tissue loss. He underwent percutaneous bilateral 
common iliac artery angioplasty and stent deploy- 
ment procedures with a resultant acute aortoiliac 
thrombotic occlusion. This single case accounted for 
two of the immediate failures. Application of lyric 
therapy in an attempt o reestablish patency was 
ultimately unsuccessful, and the procedure was con- 
verted to an axillofemoral nd femorofemoral bypass. 
This patient died on the third day after surgery from 
disseminated intravascular coagulopathy and acute 
renal failure and represented the only procedure- 
related eath in the series. The third failed procedure 
was in a patient who had bilateral lower extremity 
ischemia manifested by rest pain, who had previously 
undergone retroperitoneal dissection for creation of 
an ileal conduit with subsequent pelvic radiation for 
carcinoma of the bladder. Attempted balloon dilata- 
tion and stent deployment resulted in a common iliac 
artery injury with extravasation f the contrast me- 
diurn. Balloon control ofprograde flow could not be 
established, and an urgent retroperitoneal dissection 
with direct repair of the iliac artery injury and creation 
of a femorofemoral crossover bypass was performed. 
A fourth common iliac artery dilatation and stent 
placement occluded during surgery and was con- 
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Table I I I .  Preprocedure and postprocedure 
pressure ratios 
Preintervention Postintervention 
Aortoiliac procedures 
High thigh-brachial 0.60 _+ 0.13 
index 
Femoropopliteal 
procedures 
Ankte-brachial index 0.54 _+ 0.14 
Popliteal/fibial procedures 
Ankle-brachial ndex 0.46 -+ 0.18 
All procedures 
High thigh-brachial or 0.57 _+ 0.15 
Ankle-brachial ndex 
0.96 _+ 0.12 
0.89 + 0.20 
0.87 + 0.22 
0.93 + 0.13 
Values are mean _+ SD; p < 0.05. 
verted to an aortobifemoral bypass procedure. The 
fifth immediate failure in the aortoiliac position rep- 
resented the single instance of  failure as a result of  an 
inability to cross the lesion with a wire. This patient 
underwent a subsequent common iliac-profunda 
femoris bypass procedure. The resultant initial suc- 
cess rate, defined previously to include the combina- 
tion of dimination of translesion pressure gradient, 
improvement in symptomatic status, and successful 
anatomic result was 55 of  60 cases for the aortoiliac 
procedures (92%). 
There was a significant increase in the high thigh- 
brachial artery indexes after completion of  these pro- 
cedures. Table III outlines mean systolic pressure 
ratios measured before and after the procedure for 
each location separately and for the combined series. 
Of  the 32 femoropopliteal angioplasty procedures 
that were attempted, all were for stenotic lesions. 
There were four immediate failures. In each of these 
instances the lesions were crossed and angioplasty was 
performed, but there was no improvement in the 
pressure gradient. All of these failures were in patients 
who had critical limb ischemia; two had tissue loss 
and poor outflow. Neithe~ had a satisfactory bypass 
alternative and both underwent below-knee amputa- 
tions, which healed successfully. The other two pa- 
tients had rest pain and were converted to open 
surgical procedures at the time of  their failed endo- 
vascular procedure. The  initial success rate for this 
group was 28 o f  32, or 88%, Postprocedure anlde- 
brachial indexes were signi~canfly improved as com- 
pared with preprocedure measurements (Table Ill). 
There were 17 below~knee popliteal and tibial 
angioplasty procedures performed, all for stenotic 
lesions. Tibial angioplasty procedures were per- 
formed over 0.018 inch smali~vessel Glidewires 
(Meditech) using lower-profile SUB-4 smallwessel 
balloon dilatation catheters (Meditech). The initial 
Table IV. Minor and major complications 
Complicario~ N~mber Perce~t 
Dissection 4 3.6 
Hematoma 2 1.8 
Pseudoaneuwsm 1 0.9 
Cardiac arrhythrnia 1 0.9 
Arterial wall rupture 1 0.9 
Acute arterial occlusion 3 2.7 
Acute renal failure 1 0.9 
success rate was 16 of 17, or 94%, The one Failure was 
an inability to significantly improve the distal ankle 
pressure after anterior tibial artery angioplasty. This 
patient with tissue loss and poor runoff went on to 
have a below-kaaee amputation. Overall, the mean 
postprocedure anlde-brachial index was significantly 
higher in this group when compared with the mean 
preprocedure index (Table II I p. 
In the series of t09 endovascular p ocedures, 16 
(15%) were performed as an adjunct m a standard 
vascular surgical procedure. Eight iliac and Lwvo su- 
perficial femoral angioplasty procedures were per- 
formed as complementary inflow procedures to aug- 
ment lower extremity revascularizafions. Two of  
these procedures failed when their tibial grafts oc- 
cluded, and the patients went on to undergo below- 
knee amputations. This group has a continued suc- 
cess rate of 80% ~8 of 10), with a mean follow-up of 
10.7 months. An additional external iliac-profunda 
bypass performed istal to a common iliac angio- 
plasty and stent placement for ischemic rest pare 
occluded at 6 months. This patient, however, re- 
mained symptomatically improved~ with an improve- 
ment of 0.30 in anlde-brachiai index and a parent 
stent by duplex scan and is therefore considered a
continued success. 
Six tibial angioplasty procedures were performed 
in conjunction with femoral-to-above-knee popliteal 
bypass procedures to augment outflow. One patient 
had early graft thrombosis with critical imb ischemia~ 
which was treated with successful graft revision. At~ 
inrraoperative angiographic scan demonstrated con- 
tinued patency of the previous tibial angioplasty. 
With this failure the success rate for this group was 
five of six (83%) with a mean follow-up of 8.6 months. 
Minor and major complications are summarized in Ta- 
ble IV. The overall complication rate was 11%. 
Follow-up has been achieved in all patients, with a 
range of  2 to 31 months and a mean of 15,7 months. 
Of the 60 aortoiliac procedures that were performed, 
five failed immediately, and an additional seven pro- 
cedures demonstrated deterioration i the follow-up 
period, for a continued success rate of 80% (48 of 60). 
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Table V. Initial and continuedsuccess rates 
of procedures by length of lesion 
Initial Continued 
Lesion length Number success rate success rate 
<5 cm 70 67 /70  (96%) 62/70 (82%) 
>5 cm 39 32/39 (82%)* 24/39 (62%)* 
*Initial and continued success rates ignificantly ess (p < 0.05) for 
lesions > 5 cm. 
Two of these seven procedures were combined with 
surgical procedures as described above, which failed 
and required below-lmee amputation. One patient 
had deterioration ofhis high thigh pressure, return of 
his rest pain, and outflow stenosis at the site of his 
previously placed iliac stent. This patient was treated 
successfully with a second stent placed at the site of 
the stenosis. The remaining five failed procedures 
were manifested by worsening of high thigh gradients 
and symptoms related to restenosis (two cases) and 
stent occlusion (three cases) and were all treated 
successfully with femorofemoral crossover grafts. 
Of the 32 femoropopliteal procedures performed, 
four failed immediately, and an additional four pro- 
cedures demonstrated deterioration during the fol- 
low-up period, for a continued success rate of 75% 
(24 of 32). The four patients whose procedures failed 
in the follow-up period had deterioration of ankle- 
brachial indexes, worsening of clinical symptoms, and 
associated duplex evidence ofrestenosis at the site of 
angioplasty. All were treated successfully with femo- 
ropopliteal bypass grafts. 
In the popliteal/tibial angioplasty group, reste- 
nosis developed in two patients who were initially 
treated for critical limb ischemia that manifested by 
tissue loss, for a continued success rate of 82% (14 of 
17). Both had poor runoff and no reconstructive 
alternative as a result of restenoses with worsened 
ischemia nd these patients ubsequently underwent 
below-knee amputations. 
Fifteen of the 109 procedures were performed 
after using duplex scanning as the sole preoperative 
imaging method. Eight of these were iliac artery 
stenoses, five femoropopliteal stenoses, and two tibia] 
stenoses. Intraoperative angiographic s ans were per- 
formed to verify the duplex findings, which were 
universally accurate in this small group. The initial 
and continuing success rates were 93% (14 of 15), 
with a mean follow-up period of 13 months. 
When initial and continued success rates were 
evaluated by lesion characteristics, as described in 
Table II, only the length of the lesion was identified 
as a significant predictor of failure (Table V). Of  the 
109 lesions treated, 70 were less than 5 cm in length, 
and 39 measured greater than 5 cm in length. The 
initial success rate for lesions less than 5 cm was 67 of 
70 (96%), which was significantly greater than success 
rates for those that measured longer than 5 cm (32 of 
39; 82%). This association held true for continued 
success rates as well, with 62 of 70 lesions (86%) 
measuring less than 5 cm maintaining a successful 
result as compared with 24 of 39 lesions (62%) 
greater than 5 cm remaining successful (p < 0.05). 
In the current series, the location of the lesion, 
occlusion versus stenosis, status of runoff, or place- 
ment ofa stent did not alter success rates ignificantly. 
Table VI and Fig. 1 demonstrate life-table analysis for 
continued success of all lesions treated. Cumulative 
success rates for all lesions treated were 81% and 72% 
after I and 2 years, respectively. 
DISCUSSION 
Performance of therapeutic endovascular p oce- 
dures has become increasingly common since the first 
therapeutic use of a vascular catheter by Fogarty et al. 
in 1963. 3 This initial report of a balloon catheter 
embolectomy and thrombectomy was followed in 
1964 by Dotter and ~udldns,  4 who recommended 
transhiminal dilatation of occlusive vascular lesions 
with coaxial dilating catheters. This initiated aprocess 
of evolution that has seen dramatic improvements in 
technique and the continued evelopment of more 
sophisticated devices, 6 
We have also seen a similar evolutionary process in 
the valuation of these procedures within the surgical 
community. Initially accustomed to performing an- 
giographic scans for purposes of diagnosis before 
performing a surgical reconstruction, most surgeons 
relinquished these diagnostic responsibilities to col- 
leagues in radiology. The specialty of interventional 
radiology then developed as an extension to these 
original diagnostic practices. 
As the use of angioplasty techniques expanded, 
the indications for treatment broadened and new 
populations of patients were offered therapeutic alter- 
natives that some vascular surgeons have been reluc- 
tant to endorse. Concerns were expressed over these 
newly defined indications and the reported differ- 
ences in the results between endovascular nd stan- 
dard surgical alternatives. Although the deficiencies 
of these early methods of reporting have been empha- 
sized, 7,8 as successful reports accumulated indicating 
that balloon angioplasty could be effective and 
safe, 9-15 surgeons cautiously began to reexamine their 
role in the management of patients who have lesions 
that are amenable to endovascular intervention. 
JOURNAL OF VASCULAR SURGERY 
Volume 24, Number 6 Silva et al. 969 
109 
90 
A 80-  
w 
® 60-  
o 
o 
"~ 4O-  
o 
, m  
, B  
iO -  
0 i 
t 3 
| .... 
82 64  
37  I,, 
30  25  t__. 18 10 i 
t 
t 
i I I I I i i i _ - - 
6 9 12 15 18 21 24 27 30 33 36 
Time (months) 
Fig. 1. Life-table plot fcumulative clinical success for all procedures performed. 
Table VI. Life-table analysis for all procedures performed 
Interval No. at risk at No. withdrawn Interval Cumulative 
(too) start of interval No. of failures patent pa~ency rate patency (%) SE (%) 
0-1 109 10 0 ,91 100 0.0 
1-3 99 3 6 .97 91 2,74 
3-6 90 2 6 .98 88 3.21 
6-9 82 0 18 1.0 86 3.55 
9-12 64 3 17 .95 86 3.55 
12-15 44 2 5 .95 81 5.32 
15-18 37 1 6 .97 77 6.07 
18-21 30 0 5 1.0 75 6.85 
21-24 25 1 6 .95 75 7.5 
24-27 18 0 8 1.0 72 8.98 
27-30 10 1 8 .83 72 12.04 
30-33 1 0 1 1.0 60 37.9 
Some recommended that the surgeon's role 
should be one of a participant in a team approach 
directed toward delivering endovascular therapy) 6 
The vascular surgeon in this role brings to the group 
his knowledge of preoperative evaluation and the 
pathophysiologic mechanisms ofvascular disease, the 
relative risks and benefits of varying therapeutic alter- 
natives, and an expertise with noninvasive means of 
postprocedure follow-up and assessment of efficacy. 
In this scenario, typically the actual endovascular 
treatment is provided by another member of the 
team, the interventional radiologist or cardiologist, 
and the vascular surgeon manages the preoperative 
evaluation and postoperative care and is available for 
surgical intervention for any complications of the 
endovascular p ocedure. 
Although initially accepted by many, the limita- 
tions of this role have become vident, and vascular 
surgeons are now participating directly in the perfor- 
mance of endovascular procedures) 7-2° Realiziiig 
that evolving endovascular technology may comple- 
ment or supplant standard surgical alternatives and 
reluctant to accept alimited role in the management 
of our patients, many have advocated an expanded 
role for surgeons in the performance ofendovascular 
procedures and training of vascular surgical fel- 
lows.l,18, 2o 
Alternative and successful approaches to the de- 
velopment of endovascular training programs have 
included using cardiac catheterization laborato- 
Lies 18,20 and the development of freestanding facilt - 
ties. 21 Neither of these alternatives, however, was 
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immediately available to us, which resulted in our 
choice of  using the operating suite as the site for the 
development of  a program of  operative angioplasty 
and endovascular intervention. 
In our experience, we learned that the C-arm 
imaging that is available in the operating suite was 
satisfactory for the performance of  aortoiliac, femo- 
ropopliteal, and tibial angioplasty procedures. Our 
success and complication rates are comparable with 
those reported in other series for procedures that are 
performed by interventional radiologists who were 
worldng alone or with vascular surgeons. 9-~s Simi- 
larly, our initial success rate (108 of 109 procedures) 
in crossing the occlusive lesions with a guidewire has 
confirmed our bias that surgeons can readily apply 
their technical knowledge of  catheter and wire tech- 
niques to a practice of  operative angioplasty and stent 
placement. 
It  is lmown that the short-term and long-term 
results are influenced by the characteristics of the 
lesion treated. 22,2a In our series, the length of  the 
lesion was a predictor of the clinical success; treated 
lesions that were shorter than 5 cm had improved 
initial and continued success rates compared with 
lesions that were longer than 5 cm. Other factors uch 
as lesion location, status of runoff, and concomitant 
placement of a stent did not have a significant impact 
on our early results. We anticipate, however, that 
long-term follow-up may confirm the significant im- 
pact of  these variables among the treatment group. It 
is our goal to continue a program of  surveillance for 
this group, which should contribute some under- 
standing to the significance of  these factors in deter- 
mining the efficacy of endovascular p ocedures. 
The establishment of this program has enabled us 
to provide our vascular surgical trainees with experi- 
ence that is sufficient o surpass the recommended 
minimal guidelines established by the SVS/ISCVS 1 
for each of the last 3 years. As new technology be- 
comes available, the ongoing presence of this pro- 
gram should enable us to introduce technical innova- 
tions. 
Using the experience demonstrated in this series, 
we recently have attained privileges to use the arte- 
riography suite in one of our affiliate institutions. This 
is an essential step and has been stimulated by our 
desire to eliminate the separate preprocedural cterio- 
graphic scan. In many of our patients, it is advanta- 
geous to proceed with the interventional therapy at 
the time of the diagnostic arteriogralShic scan. An- 
other approach, as reflected in 15 of our cases, has 
been the identification of  the occlusive lesion with a 
preoperative duplex ultrasound scan, thereby elimi- 
nating preoperative diagnostic arteriographic scans. 
This suggests that we can significantly reduce the 
overall cost of treatment in two ways: by expanding 
the role of  preoperative duplex ultrasound scans, and 
by performing angiographic scans and therapeutic 
intervention during the same procedure. 
We recommend that vascular surgeons become 
involved in the selection and performance of endo- 
vascular procedures in the operating room as well as 
in the angiography suite. By establishing an indepen- 
dent interventional program we plan to maintain an 
active role in the future development ofendovascular 
surgical procedures. 
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DISCUSSION 
Dr. Frank J. Veith (Bronx, N.Y.). I certainly applaud 
Dr. Silva's presentation and generally agree with his con- 
clusions, although I am not sure that duplex scanning can 
regularly replace pretreatment arteriographic s ans. I have 
one comment and two questions. 
The main comment I would like to make is that vascular 
surgeons must become proficient with C-arm digital fluo- 
roscopy and catheter-guidewire techniques to simplify and 
improve many of their standard operations. In this regard, 
at this meeting last year, Drs. Parsons, Marin, and Veith and 
their colleagues reported on our technique of fluoroscopi- 
cally assisted thromboembolectomy (Ann Vase Surg 1996; 
10:201). Using this technique, the vascular surgeon can 
navigate tortuous, diseased, clot-filled iliac arteries. Then 
using a doublequmen balloon catheter passed over a wire, 
the clot can be removed, stenotic lesions can be corrected 
by angioplasty and stents, and unsuspected retained clot 
can be removed: By visually controlling the inflation of the 
contrast-filled balloon, overinflation and damage to normal 
or diseased arteries, which is common with standard bal- 
loon catheters used without fluoroscopic guidance, can be 
avoided. 
Another example of the use of digital C-arm fluoros- 
copy and catheter and guidewire techniques to improve or 
simplify standard operative procedures i  the use of double- 
lumen balloon catheters to obtain proximal and distal con- 
trol when surgical access is difficult o r  impossible. This 
technique isparticularly valuable with arteriovenous fi tulas 
and false aneurysms, especially in heavily infected fields. 
The same techniques can also be used to perform superior 
intraoperative angiographic scans, Cine techniques with 
digital fluoroscope provide a dynamic measure of flow 
through a bypass graft. Moreover, the entire bypass graft 
plus its inflow and outflow tracts can be visualized mad 
unexpected lesions can be treated without doing extensive 
open operations. 
Thus there are many reasons why vascular surgeons 
should master the catheter-guidewire techniques and digi- 
tal C-arm fluoroscopy mentioned here. The ability to per- 
form balloon angioplasty and stenting is only one such 
reason. 
My first question to the authors relates to their appar- 
ently higher-than-usual proportion of patients with claudi- 
cation in their report today.-Do the authors have a lower 
threshold for performing endovascular interventions than 
standard operations? In this regard, I thiN< we must be 
carefial to be sure we do not fail into the same trap as some 
of our interventional colleagues do and treat lesions imply 
because they are there. 
My second question regards how the authors first 
learned to perform these procedures. Who taught hem? 
We must be sure to get appropriate instruction, help, and 
consultation i this regard, lest we be subject o the criti~ 
cism of learning on our patients. I enjoyed this interesting 
and important paper and appreciate he chance to discuss it. 
Dr. Michael B. Silva, Jr. Thank you, Dr. Veith. Let 
me speak first to your suggestion that duplex ultrasono- 
graphic scans alone may not be effective in the preoperative 
diagnosis of all lesions that are potentially treatable by 
endovascular means. We agree. In this series only 15 of the 
109 procedures were performed solely on the basis of 
duplex criteria. Although we are expanding our use of 
preoperative duplex scanning to reduce our reliance on 
traditional anglographic scans, we realize that there are a 
number of patients with multilevel disease who will require 
a more detailed preprocedure diagnostic evaluation for 
which the combination of duplex ultrasound and C-arm 
fluoroscopy may not be appropriate. To this end, we have 
obtained credentials to perform angiographic scans in the 
radiographic suite in one of our atfiliate institutions. This 
may allow us to offer our patients who have more complex 
disease the opportunity to have both their diagnostic eval- 
uation and therapeutic intervention during a single procedure. 
Regarding the number of  patients with clandicarion i
our series, a little over one half of these patients were 
treated for disabling clandication refractory to smoking 
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cessation, exercise regimens, and lifestyle modification. Al- 
though this may represent an expanded role for treatment 
on the basis of this indication when compared with surgical 
series of standard surgical therapeutics, we believe that it is 
appropriate on the basis of the risk-benefit ratio for endo- 
vascular procedures. We agree that lesions should not be 
treated simply because they are there. In this series, all lesions 
had demonstrable gradients and associated symptoms. 
The question of how one learns the techniques in- 
volved in the performance of endovascular therapeutics i  
an important one. The first author of this report underwent 
a formal 1-year fellowship in diagnostic and therapeutic 
angiographic endovascular intervention. The second and 
third authors had substantial experience in the develop- 
ment and evaluation of laser-assisted ang!oplasty proce- 
dures. This experience has been disseminated through the 
division by a policy of planned proctoring. We believe that 
the vascular surgeon is ideally suited to perform catheter- 
based techniques. A number of the procedures that are 
performed routinely in the conduct of a vascular surgical 
practice, such as placement of indwelling central venous 
catheters, placement of  Swan-Ganz catheters, placement of 
arterial ines, placement of vena cavai interruption filters, 
catheter embolectomy, and thrombectomy, lend them- 
selves to th e development of skillful catheter-based tech- 
niques. Addressing that issue, it should be noted that of the 
109 procedures performed, in only one instance was the 
procedure described as a failure on the basis of an inability 
to cross the lesion with the wire and the therapeutic device. 
Dr. John J. Ricotta (Buffalo, N.Y~). One of the big 
advantages that you can offer to us has to do with what Dr. 
Veith said before, which is to start to work on algorithms 
for diagnosis of when to use duplex scans and when to 
combine duplex with angiographic s ans. From a hospital 
administrator's point of view, this is going to be particularly 
attractive if you can show that it is cost-effective and avoids 
two trips to the hospital or two trips to the angiography 
suite. I think that that's a very important thing for us as a 
Society, and you and people who are doing this, to concen- 
trate on. 
I am a little bit concerned about hat common femoral 
lesion. I am a little concerned that we may be getting so far 
in bed with the devil that we're going to end up looking like 
the devil. It's going to be important for us, as we go ahead 
with this technology, to also define some real indications of 
when patients are best treated with surgery and when 
patients are best treated with angioplasty. Again, that's a 
challenge I think perhaps our Issues Committee, or some- 
body in this Society, can start to look at. If we start doing 
everything the radiologists do, we may live to regret it. 
Dr. Silva. Let me respond first to the issue of how to 
reduce costs. In our institution we looked at the cost of  
these procedures on the basis of the site within the hospital 
where they were performed, and the results were interest- 
ing, Operating suite charges are based on the time required 
for the procedure. Charges in the radiology suite and 
cardiology suite are based on the procedure itself. As an 
example, for an aortogram with lower extremity runoff and 
iliac artery angioplasty performed in approximately 11/2 
hours, the charges were actually 5% less when performed in 
the operating room than those generated by use of the 
cardiology suite or angiography suite. It is evident hat the 
cost-effectiveness in the operating room can be further 
improved by reducing the overall time of the procedure 
itself. To that end we have made such modifications as 
holding pressure in the recovery room rather than in the 
operating suite. 
To reduce the overall costs to the health care system, 
we are focusing on two areas. First, by expanding our role 
of preprocedure duplex ultrasound scanning to evaluate 
patients who have isolated superficial femoral or external 
iliac artery stenoses, we can eliminate the cost of the diag- 
nostic arteriogram. Second, by using the angiographic suite 
for patients who have more complex multilevel disease, we 
should be able to identify patients who would benefit from 
therapeutic endovascular intervention during the same pro- 
cedure. 
As to the issue of sleeping with the devil, I agree with 
you that the techniques we have described o mimic those 
used in interventional radiology. Of course, surgeons be- 
gan this process in the 1960s, and many older surgeons 
recall doing all of their own diagnostic arteriographic s ans. 
I think that to participate in the future of vascular surgery, 
which will encompass more and more endovascular tech- 
niques, we will need to have both procedural s dlls as well as 
diagnostic apabilities, and we will have to revisit some of 
those skills that we readily relinquished to our colleagues in
interventional radiology in the past decades. 
As for the 20-minute surgical repair of the common 
femoral lesion, I can assure you that that angioplasty took 
only 15 minutes and that the patient was doing well at her 
1-year follow-up examination. 
Dr. Thomas F. Panetta (Brooklyn, N.Y.). Clearly, 
vascular surgeons are both eager and anxious to gain expe- 
rience in endovascular techniques, and I think you and your 
group have provided an excellent means with careful fore- 
thought, which probably relates to your excellent results. I 
have three questions, though, relating to this. 
First, what is your relationship with your interventional 
radiologists? Has this been a part of your approach to this? 
It seems that you're trying to avoid the preoperative anglo- 
gram and substitute the duplex evaluation. Along that line, 
if you're performing the angiographic s an in the operating 
room, are you getting as complete an angiogram? This may 
be difficult to do with the C-arm and requires afair amount 
of images. Are you doing as complete an angiogram as you 
should and therefore avoiding proximal and distal injuries 
that could affect your primary repair? 
Again, I also echo Dr. Veith's remarks about not cor- 
rupting our principles with regard to treating patients with 
claudication and liberalizing our indications for these pro- 
cedt~res. 
Dr. Silva. As to the issue of being able to perform a 
complete aortogram with bilateral ower extremity artery 
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runoff using the C-arm, we agree that the facilities in our 
angiography suite are superior to those of our operating 
room; and as mentioned previously, we are expanding our 
practice to include the diagnostic arteriographic s ans for 
all of our vascular surgical procedures, which we perform 
ourselves in the radiology suite. 
As to the relationship with our interventional r diolo- 
gists, as you might imagine, it has become a bit more 
competitive, but it remains acollegial one nonetheless. We 
have stressed that this is an important part of our surgical 
practice as vascular surgeons and that it is a necessary part of 
our training for our vascular fellows. To learn from one 
another and foster our mutual development, we have es- 
tablished a combined conference wherein we discuss endo- 
vascular procedures performed by the Division of Vascular 
Surgery and the Department ofRadiology. 
As to the issue of liberalizing indications, I think that 
indications will probably be expanded to include pa- 
tients who have a level of clandication for which we would 
not offer a more complicated surgical solution, and 
this has to be based on the risk-benefit ratio of the proce- 
dure. If an isolated angioplasty procedure can be per- 
formed percutaneously with a local anesthetic on an outpa- 
tient basis with acceptable levels of risk and we can demon- 
strate I-year to 2-year efficacy rates in the 70% to 80% 
range, isn't this an acceptable solution for moderate to 
severe claudication? Our patients thiN< so, and we are 
inclined to agree. 
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